Sisunatovir
- Generic Name
- Sisunatovir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H22F4N4O
- CAS Number
- 1903763-82-5
- Unique Ingredient Identifier
- KE63TTO7WK
- Background
Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV).
- Indication
用于呼吸道合胞病毒（RSV）引起的上呼吸道感染。
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.
- Conditions
- Interventions
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 40
- Registration Number
- NCT06105983
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection
- Conditions
- Interventions
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT06079320
- Locations
- 🇺🇸
Ascension St. John Hospital, Grosse Pointe Woods, Michigan, United States
🇺🇸Oakland Medical Research, Troy, Michigan, United States
🇺🇸Javara - Mankato Clinic, Mankato, Minnesota, United States
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 25
- Registration Number
- NCT05994963
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05987072
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
🇨🇳Huashan Hospital, Fudan University, Shanghai, Shanghai, China
🇨🇳Huashan Hospital Fudan University, Shanghai, Shanghai, China
A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT05878522
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants
- First Posted Date
- 2023-02-03
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05712460
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.